CME Group (CME) is back in focus after reporting record October trading activity in interest rate and U.S. Treasury futures, as investors responded to rising Federal Reserve rate hike expectations.
The recent surge in interest rate trading has coincided with a strong run in CME Group’s shares, with a 10.17% 1‑month share price return contributing to a 14.61% year to date gain and supported by a 5‑year total shareholder return of 68.99%. This suggests momentum has been building rather than fading.
Spot other exchanges and risk-focused operators showing similar trading momentum to CME Group by scanning our curated list of 20 high quality undiscovered gems.After a sharp run and record activity in its core interest rate complex, CME Group now asks you to weigh a richer share price against a still risk heavy backdrop. Does that trade off still favour new buyers?
Most Popular Narrative: 2% Undervalued
CME Group last closed at $309.09, which sits slightly below the analyst consensus Narrative fair value of $316. According to the analyst consensus Narrative on Simply Wall St, that small gap reflects a view that most of the earnings power and risks are already captured in today’s price, with only a modest margin of upside implied.
New product introductions, such as single stock futures, compute futures on NVIDIA H100 rental costs, E mini Equity Factor futures, wind power contracts, leveraged loan index futures and a planned entry into European dairy, together with ongoing technology driven efficiencies from cloud migration and tokenization projects, give CME Group more ways to grow transaction and market data revenue while supporting high net margins.
See why 59 investors see CME Group as 2% undervalued.
Result: Fair Value of $316 (UNDERVALUED)
Still, the CME Group narrative can be knocked off course if rivals gain share in key rate or energy contracts, or if regulatory outcomes around crypto and perpetual futures reduce the value investors assign to newer products.
Find out about the key risks to this CME Group narrative.
Another View: What The SWS DCF Model Says
The analyst narrative frames CME Group as roughly fairly priced with a small upside to $316. A different tool, the Simply Wall St DCF model, paints a cooler picture. On that basis, an estimated future cash flow value of $257.44 suggests CME shares look overvalued at $309.09.
Investors weighing these two lenses need to ask which matters more for them: the earnings based story or the cash flow math.
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out CME Group for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 36 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
Whether you feel cautious or optimistic about CME Group after all of this, the key is to understand both sides of the story and decide on your approach before sentiment shifts. The fastest way to pressure test your view is to weigh the 3 key rewards and 2 important warning signs
Looking for more ideas beyond CME Group?
If CME Group has sharpened your thinking, do not stop here. Broader idea hunting now can help you build a more resilient portfolio tomorrow.
- Target companies with strong earnings power and attractive entry points by scanning our 36 high quality undervalued stocks.
- Prioritise income and resilience by zeroing in on 5 dividend fortresses that can support a steadier cash flow profile.
- Reduce overall portfolio stress by focusing on 30 resilient stocks with low risk scores that score well on financial strength and volatility.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com